marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
ImmuCell Corporation Balance Sheet 2011-2024 | ICCC
Annual Balance Sheet ImmuCell Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
10.2 M | 3.43 M | -9.05 M | 1.55 M | 2.13 M | 6.74 M | 5.16 M | -2.14 M | 1.65 M | 46.3 K | -1.18 M | -1.41 M | 659 K |
Long Term Debt |
10.5 M | 9.19 M | 1.03 M | 9.4 M | 7.15 M | 8.42 M | 8.64 M | 2.88 M | 3.09 M | 746 K | 896 K | 1.09 M | 1.27 M |
Long Term Debt Current |
644 K | 31.8 K | 108 K | 101 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
14.6 M | 11.4 M | 9.35 M | 9.4 M | 7.21 M | 8.42 M | 8.64 M | 2.92 M | 3.17 M | 785 K | 929 K | 1.17 M | 1.34 M |
Total Current Liabilities |
4.2 M | 3.07 M | 2.53 M | 2.21 M | 2.5 M | 2.57 M | 2.06 M | 2.06 M | 818 K | 1.01 M | 636 K | 666 K | 635 K |
Total Liabilities |
18.8 M | 14.5 M | 11.9 M | 12.1 M | 9.7 M | 11 M | 10.7 M | 4.98 M | 3.99 M | 1.79 M | 1.56 M | 1.84 M | 1.97 M |
Deferred Revenue |
- | - | - | - | - | - | 24.1 K | 33.9 K | - | 6.69 K | - | - | 8.25 K |
Retained Earnings |
-12 M | -6.23 M | -3.74 M | - | -2.64 M | -1.34 M | 979 K | 1.15 M | 639 K | -575 K | -407 K | -525 K | -614 K |
Total Assets |
43.8 M | 44.9 M | 44.5 M | 40.4 M | 38.7 M | 32.7 M | 34.3 M | 24.7 M | 14.6 M | 11.1 M | 11 M | 11 M | 11 M |
Cash and Cash Equivalents |
979 K | 5.79 M | 10.2 M | 6.95 M | 6.29 M | 2.52 M | 3.8 M | 5.15 M | 1.57 M | 850 K | 2.27 M | 2.67 M | 782 K |
Book Value |
25 M | 30.4 M | 32.6 M | 28.3 M | 29 M | 21.7 M | 23.6 M | 19.7 M | 10.6 M | 9.26 M | 9.4 M | 9.19 M | 9.02 M |
Total Shareholders Equity |
25 M | 30.4 M | 32.6 M | 28.3 M | 29 M | 21.7 M | 23.6 M | 19.7 M | 10.6 M | 9.26 M | 9.4 M | 9.19 M | 9.02 M |
All numbers in USD currency
Quarterly Balance Sheet ImmuCell Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
9.42 M | 9.8 M | 10.2 M | 10.5 M | 12.3 M | 9.73 M | 9.98 M | 9.19 M | 10.5 M | 10.7 M | 698 K | 1.03 M | 193 K | 383 K | 9.31 M | 9.5 M | 9.72 M | 9.86 M | 8.56 M | 8.42 M | 8.63 M | 8.85 M | 9.06 M | 9.27 M | 9.48 M | 9.12 M | 9.19 M | 8.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 839 K | 882 K | 929 K | 988 K | 1.04 M | 929 K | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 1.34 M | 1.34 M | 1.34 M | - |
Total Non Current Liabilities |
13.6 M | 13.8 M | 14.2 M | 14.6 M | 15.2 M | 13 M | 11.1 M | 11.4 M | 11.7 M | 10.7 M | 11 M | 9.35 M | 9.6 M | 9.43 M | 9.65 M | 9.87 M | 9.87 M | 9.87 M | 9.87 M | 7.21 M | 7.21 M | 7.21 M | 7.21 M | 8.42 M | 8.42 M | 8.42 M | 8.42 M | 8.64 M | 8.64 M | 8.64 M | 8.64 M | 2.92 M | 2.92 M | 2.92 M | 2.92 M | 3.13 M | 3.13 M | 3.13 M | 3.13 M | 785 K | 785 K | 785 K | 785 K | 929 K | 929 K | - | - | - | - | - | 1.28 M | 1.34 M | - | - | - |
Total Liabilities |
18 M | 18.4 M | 18.4 M | 18.8 M | 18.5 M | 17.2 M | 15 M | 14.5 M | 14.4 M | 13.2 M | 13.3 M | 11.9 M | 11.8 M | 11.5 M | 11.8 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 11 M | 11 M | 11 M | 11 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 4.98 M | 4.98 M | 4.98 M | 4.98 M | 3.93 M | 3.93 M | 3.93 M | 3.93 M | 1.79 M | 1.79 M | 1.79 M | 1.79 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 1.84 M | 1.84 M | 1.84 M | 1.84 M | 1.97 M | 1.97 M | 1.97 M | 1.97 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 24.1 K | 24.1 K | 24.1 K | 24.1 K | 24.1 K | 24.1 K | 24.1 K | 33.9 K | 33.9 K | 33.9 K | 33.9 K | - | - | - | 6.69 K | 6.69 K | 6.69 K | 6.69 K | 6.69 K | - | - | 250 K | - | - | - | - | 8.25 K | 8.25 K | 8.25 K | 8.25 K | 8.25 K |
Retained Earnings |
-14.7 M | -14 M | -12.4 M | -12 M | -10.9 M | -9.93 M | -8.55 M | -6.23 M | -4.56 M | -3.69 M | -3 M | -3.74 M | -3.81 M | -3.96 M | -4.1 M | -3.66 M | -3.66 M | -3.66 M | -3.66 M | -2.64 M | -2.64 M | -2.64 M | -2.64 M | -1.34 M | -1.34 M | -1.34 M | -1.34 M | 979 K | 979 K | 979 K | 979 K | 1.15 M | 1.15 M | 1.15 M | 1.15 M | 639 K | 639 K | 639 K | 639 K | -575 K | -575 K | -575 K | -575 K | -407 K | -407 K | -407 K | -407 K | -525 K | -525 K | -525 K | -525 K | -614 K | -614 K | -614 K | -614 K |
Total Assets |
44.4 M | 41.9 M | 43.1 M | 43.8 M | 44.5 M | 44 M | 43.1 M | 44.9 M | 46.4 M | 46 M | 46.7 M | 44.5 M | 44.2 M | 43.7 M | 39.6 M | 40.3 M | 40.3 M | 40.3 M | 40.3 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M | 32.7 M | 32.7 M | 32.7 M | 32.7 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 24.7 M | 24.7 M | 24.7 M | 24.7 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11 M | 11 M | 11 M | 11 M | 11 M | 11 M | 11 M | 11 M | 11 M | 11 M | 11 M | 11 M |
Cash and Cash Equivalents |
3.81 M | 1.32 M | 960 K | 979 K | 1.99 M | 1.45 M | 3.1 M | 5.79 M | 8.83 M | 11 M | 5.84 K | 10.2 M | 10.5 M | 10.7 M | 6.81 M | 6.95 M | 6.95 M | 6.95 M | 6.95 M | 6.29 M | 6.29 M | 6.29 M | 6.29 M | 2.52 M | 2.52 M | 2.52 M | 2.52 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 5.15 M | 5.15 M | 5.15 M | 5.15 M | 1.57 M | 1.57 M | 1.57 M | 1.57 M | 850 K | 850 K | 850 K | 850 K | 2.27 M | 2.27 M | 2.27 M | 2.27 M | 2.67 M | 2.67 M | 2.67 M | 2.67 M | 782 K | 782 K | 782 K | 782 K |
Book Value |
26.4 M | 23.5 M | 24.6 M | 25 M | 26 M | 26.9 M | 28.2 M | 30.4 M | 32 M | 32.8 M | 33.4 M | 32.6 M | 32.5 M | 32.3 M | 27.9 M | 28.3 M | 28.3 M | 28.3 M | 28.3 M | 29 M | 29 M | 29 M | 29 M | 21.7 M | 21.7 M | 21.7 M | 21.7 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 9.26 M | 9.26 M | 9.26 M | 9.26 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.19 M | 9.19 M | 9.19 M | 9.19 M | 9.02 M | 9.02 M | 9.02 M | 9.02 M |
Total Shareholders Equity |
26.4 M | 23.5 M | 24.6 M | 25 M | 26 M | 26.9 M | 28.2 M | 30.4 M | 32 M | 32.6 M | 33.2 M | 32.6 M | 32.5 M | 32.3 M | 27.9 M | 28.3 M | 28.3 M | 28.3 M | 28.3 M | 29 M | 29 M | 29 M | 29 M | 21.7 M | 21.7 M | 21.7 M | 21.7 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 9.26 M | 9.26 M | 9.26 M | 9.26 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.19 M | 9.19 M | 9.19 M | 9.19 M | 9.02 M | 9.02 M | 9.02 M | 9.02 M |
All numbers in USD currency